Inside Health Policy, June 03, 2020. The Congressional Research Service says Congress could rein in FDA’s COVID-19 policies by passing a law, and NCHR explains why that is a good idea.
Read More »Our Interviews, Blogs & OpEds
Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals
Stat News, May 19, 2020. Two FDA officials recuse themselves from COVID-19 vaccine approvals because of conflicts of interest.
Read More »MLB, players’ union are working to salvage season, and the next two weeks are critical
The Washington Post, May 22, 2020. The MLB & players’ union are working to salvage the baseball season and NCHR explains why the plan is too risky for players.
Read More »Tests for COVID-19: Has the FDA said yes too many times?
The Hill Opinion Contributors, May 6, 2020. Most tests being sold in the U.S. aren’t proven to be accurate by unbiased scientists. Here’s what you need to know.
Read More »Everything is designed for men, even drugs
Vox, January 16, 2020. Designing medicine around the “average man” is so dangerous. We need more inclusivity in clinical trials — for women, for people over 65, and for people of color.
Read More »